Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.42 |
| ▸ | LMNA | P02545 | 3/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | RGS12 | O14924 | 2/20 | 0.42 |
| ▸ | USP2 | O75604 | 2/20 | 0.42 |
| ▸ | POLB | P06746 | 2/20 | 0.42 |
| ▸ | THRB | P10828 | 2/20 | 0.42 |
| ▸ | PKM | P14618 | 2/20 | 0.42 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.42 |
| ▸ | APEX1 | P27695 | 2/20 | 0.42 |
| ▸ | BRCA1 | P38398 | 2/20 | 0.42 |
| ▸ | RECQL | P46063 | 2/20 | 0.42 |
| ▸ | BLM | P54132 | 2/20 | 0.42 |
| ▸ | GNAI1 | P63096 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29728715 | 1.00 | ALDH1A1 (0.42) | ALDH1A1LMNAALOX15MEN1RGS12 | |
| SCHEMBL4146720 | 0.85 | ALDH1A1 (0.48) | ALDH1A1LMNAALOX15MEN1RGS12 | |
| SCHEMBL3690501 | 0.79 | ALDH1A1 (0.46) | ALDH1A1LMNAALOX15BLMMAPT | |
| SCHEMBL7721860 | 0.79 | TSHR (0.41) | ALDH1A1LMNAALOX15BLMMAPT | |
| SCHEMBL14873544 | 0.77 | SIGMAR1 (0.42) | ALDH1A1LMNAMAPTSIGMAR1TSHR | |
| SCHEMBL673129 | 0.76 | ALDH1A1 (0.41) | ALDH1A1LMNAALOX15MEN1RGS12 | |
| SCHEMBL3724687 | 0.76 | SIGMAR1 (0.41) | ALDH1A1LMNABLMMAPTCYP1A2 | |
| SCHEMBL28347773 | 0.76 | ALDH1A1 (0.41) | ALDH1A1LMNAALOX15MEN1RGS12 | |
| SCHEMBL9549156 | 0.73 | TSHR (0.45) | ALDH1A1LMNAMAPTSIGMAR1TSHR | |
| SCHEMBL9877100 | 0.72 | ALDH1A1 (0.39) | ALDH1A1LMNAALOX15MEN1RGS12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7539006-B2 | Electrolytic solution for driving electrolytic capacitor and electrolytic capacitor | RUBYCON CORPORATION (JP) | 2009-05-26 | — | — | US | claimed |
| CN-100456398-C | Electrolyte for driving electrolytic capacitor and electrolytic capacitor | RUBYCON CORP (JP) | 2009-01-28 | — | — | CN | claimed |
| US-20070029529-A1 | Electrolytic solution for driving electrolytic capacitor and electrolytic capacitor | KOMATSU AKIHIKO | 2007-02-08 | — | — | US | claimed |
| US-20040245105-A1 | Electrolyte solution for driving electrolytic capacitor and electrolytic capacitor | RUBYCON CORPORATION (JP) | 2004-12-09 | — | — | US | claimed |
| CN-1529892-A | Electrolyte for driving electrolytic capacitor and electrolytic capacitor | 如碧空株式会社 | 2004-09-15 | — | — | CN | claimed |
| EP-1437749-A1 | ELECTROLYTE SOLUTION FOR DRIVING ELECTROLYTIC CAPACITOR AND ELECTROLYTIC CAPACITOR | Rubycon Corporation (JP) | 2004-07-14 | — | — | EP | claimed |
| CN-115255358-B | Surface modification method of metal powder material, modified metal powder material and application of modified metal powder material | 西安隆基乐叶光伏科技有限公司 | 2024-01-16 | — | — | CN | disclosed |
| US-11833204-B2 | Visible light-activatable nanoparticles for cancer immunotherapy and use thereof | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2023-12-05 | — | — | US | disclosed |
| CN-114752955-B | Method for electrochemically synthesizing N-nitroso-2-aminobenzophenone compound | 广西师范大学 | 2023-06-16 | — | — | CN | disclosed |
| US-20220370611-A1 | VISIBLE LIGHT-ACTIVATABLE NANOPARTICLES FOR CANCER IMMUNOTHERAPY AND USE THEREOF | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2022-11-24 | — | — | US | disclosed |
| CN-115255358-A | Surface modification method of metal powder material, modified metal powder material and application thereof | 西安隆基乐叶光伏科技有限公司 | 2022-11-01 | — | — | CN | disclosed |
| CN-114752955-A | Method for electrochemically synthesizing N-nitroso-2-aminobenzophenone compound | 广西师范大学 | 2022-07-15 | — | — | CN | disclosed |
| EP-1460660-B1 | ELECTROLYTIC CAPACITOR AND ELECTROLYTIC SOLUTION FOR DRIVING ELECTROLYTIC CAPACITOR | RUBYCON CORP (JP) | 2013-04-10 | — | — | EP | disclosed |
| CN-1494723-A | Electrolytic capacitor and electrolyte for driving electrolytic capacitor | 如碧空株式会社 | 2004-05-05 | — | — | CN | disclosed |
| EP-1243268-A1 | MEDICINAL COMPOSITION | Nippon Shinyaku Co., Ltd. (JP) | 2002-09-25 | — | — | EP | disclosed |
| EP-1156045-A1 | AMIDE DERIVATIVES AND DRUG COMPOSITIONS | Nippon Shinyaku Co., Ltd. (JP) | 2001-11-21 | — | — | EP | disclosed |
| US-4335245-A | REACTION OF A HYDROXYPYRIDONE WITH P-NITROSODIMETHYLANILINE FOLLOWED BY HYDROLYSIS | CIBA-GEIGY AG (CH) | 1982-06-15 | — | — | US | disclosed |
| US-4288598-A | DYE-BLEACH CATALYSTS | CIBA-GEIGY AG (CH) | 1981-09-08 | — | — | US | disclosed |
| US-4244843-A | IMPROVED WEATHERPROOFING PROPERTIES BY HOMOGENEOUS CROSSLINKING OF DIENE-ETHYLENE-PROPYLENE TERPOLYMER BLEND | MITSUBISHI BELTING, LTD. (JP) | 1981-01-13 | — | — | US | disclosed |
| US-4209596-A | Two step process for producing vulcanized rubber | MITSUBOSHI BELTING, LTD. (JP) | 1980-06-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11833204-B2 | Visible light-activatable nanoparticles for cancer immunotherapy and use thereof | CD47, PDCD1, TP53 | ALDH1A1 3091/4885LMNA 3175/4885ALOX15 2492/4885 |
| US-20220370611-A1 | VISIBLE LIGHT-ACTIVATABLE NANOPARTICLES FOR CANCER IMMUNOTHERAPY AND USE THEREOF | CD47, PDCD1, TP53 | ALDH1A1 3091/4885LMNA 3175/4885ALOX15 2492/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.